NeoPharm CO., LTD. 092730.KQ Stock
NeoPharm CO., LTD. Price Chart
NeoPharm CO., LTD. 092730.KQ Financial and Trading Overview
| NeoPharm CO., LTD. stock price | 22700 KRW |
| Previous Close | 23300 KRW |
| Open | 23200 KRW |
| Bid | 23600 KRW x 0 |
| Ask | 23650 KRW x 0 |
| Day's Range | 22750 - 23650 KRW |
| 52 Week Range | 16000 - 23650 KRW |
| Volume | 197.93K KRW |
| Avg. Volume | 76.14K KRW |
| Market Cap | 188.53B KRW |
| Beta (5Y Monthly) | 0.929484 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
092730.KQ Valuation Measures
| Enterprise Value | 37.72B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.171923 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.435 |
| Enterprise Value/EBITDA | 1.626 |
Trading Information
NeoPharm CO., LTD. Stock Price History
| Beta (5Y Monthly) | 0.929484 |
| 52-Week Change | 12.83% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23650 KRW |
| 52 Week Low | 16000 KRW |
| 50-Day Moving Average | 19687.6 KRW |
| 200-Day Moving Average | 18901.15 KRW |
092730.KQ Share Statistics
| Avg. Volume (3 month) | 76.14K KRW |
| Avg. Daily Volume (10-Days) | 108.17K KRW |
| Shares Outstanding | 7.99M |
| Float | 4.62M |
| Short Ratio | N/A |
| % Held by Insiders | 38.93% |
| % Held by Institutions | 14.86% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1.3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | 21.01% |
| Operating Margin (ttm) | 24.88% |
| Gross Margin | 69.44% |
| EBITDA Margin | 26.72% |
Management Effectiveness
| Return on Assets (ttm) | 9.29% |
| Return on Equity (ttm) | 13.81% |
Income Statement
| Revenue (ttm) | 86.8B KRW |
| Revenue Per Share (ttm) | 11099.47 KRW |
| Quarterly Revenue Growth (yoy) | -3.20% |
| Gross Profit (ttm) | 62.39B KRW |
| EBITDA | 23.2B KRW |
| Net Income Avi to Common (ttm) | 18.24B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 28.19% |
Balance Sheet
| Total Cash (mrq) | 104.8B KRW |
| Total Cash Per Share (mrq) | 13400.82 KRW |
| Total Debt (mrq) | 192.24M KRW |
| Total Debt/Equity (mrq) | 0.14 KRW |
| Current Ratio (mrq) | 11.705 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 18.07B KRW |
| Levered Free Cash Flow (ttm) | 12.98B KRW |
Profile of NeoPharm CO., LTD.
| Country | South Korea |
| State | N/A |
| City | Daejeon |
| Address | 309-8, Techno 2-ro |
| ZIP | N/A |
| Phone | 82 4 2863 0038 |
| Website | https://www.neopharm.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | 141 |
NeoPharm CO., LTD. manufactures and sells skin care products in South Korea. The company offers Atopalm, a non-steroid product for sensitive and dry skin; skin dermo-cosmetic products under the Real Barrier brand; products for sensitive, dry, oily, or trouble-prone skin under the ZEROID brand; body moisturizers under the Derma-B brand; and sport care products for athletes under the MISSION ATHELETCARE brand. NeoPharm CO., LTD. was founded in 2000 and is headquartered in Daejeon, South Korea.
Q&A For NeoPharm CO., LTD. Stock
What is a current 092730.KQ stock price?
NeoPharm CO., LTD. 092730.KQ stock price today per share is 22700 KRW.
How to purchase NeoPharm CO., LTD. stock?
You can buy 092730.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NeoPharm CO., LTD.?
The stock symbol or ticker of NeoPharm CO., LTD. is 092730.KQ.
How many shares does NeoPharm CO., LTD. have in circulation?
The max supply of NeoPharm CO., LTD. shares is 7.82M.
What is NeoPharm CO., LTD. Price to Earnings Ratio (PE Ratio)?
NeoPharm CO., LTD. PE Ratio is now.
What was NeoPharm CO., LTD. earnings per share over the trailing 12 months (TTM)?
NeoPharm CO., LTD. EPS is 0 KRW over the trailing 12 months.